Florent LAUZET
Group Partner
Siparex ETI
Member of the Executive Committee
Accueil » Our platform »
Siparex ETI - Mid-sized companies' transformative shareholder
€1,1b under management
17 investors
Funds in the investment phase:
ETI 5 – €500 M
Article 8 SFDR Fund
Company profiles:
Growth SMEs with a turnover of up to €500 M in France, Belgium and neighbouring countries
Strategy:
Buy and Build / Growth
Majority position or leading shareholder
Investment ticket:
€20 M to €50 M (possibility of joint investment)
Privileged access to primary operations
Investments.
Siparex ETI supports the development of growth ISEs to transform regional leaders into European champions.
Sectorial priorities
Health
& well-being
Energy transition
Specialty industries
Technology & Services
Food industry
Our Team.
The ETI team is present in France, with offices in Lyon, Paris, and Nantes, and abroad with offices in Brussels and Montreal.
Guillaume REBAUDET
Partner Siparex ETI
Alexandre TREMBLIN
Partner Siparex ETI
Thibaud de PORTZAMPARC
Partner Siparex ETI
Are you interested in investing
in ETI strategy?
The Investment and Development team is the key contact point for institutional and family office subscribers to our funds.
News ETI.
Mérieux Equity Partners acquires a majority stake in Piercan, the world-leading technical gloves manufacturer for the pharmaceutical and nuclear industries. Groupe Siparex invests alongside Mérieux Equity Partners through its ETI and France Nucléaire funds.
One Equity Partners Agrees to Acquire Precision Metals, Polymers & Composites Maker Clayens Group
Siparex ETI 5 exceeds its target with a final closing at €450 M and makes its 4th investment
